Market Place
Sourcing Support
All News #Library
Biotech
Oculis To Participate In Upcoming Investor Conferences
07 Apr 2026 //
GLOBENEWSWIRE
Oculis To Present At North American Neuro-Ophthalmology Society
16 Mar 2026 //
GLOBENEWSWIRE
Oculis To Participate In Upcoming Investor Conferences
05 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
04 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports 2025 Financial Results And Company Update
03 Mar 2026 //
GLOBENEWSWIRE
Oculis To Present Late-Stage Pipeline In Neuro-Ophthalmology
08 Jan 2026 //
GLOBENEWSWIRE
Oculis Announces Oversubscribed $110 Million Financing
30 Oct 2025 //
GLOBENEWSWIRE
Oculis Advances Privosegtor To Registrational In Optic Neuritis
06 Oct 2025 //
GLOBENEWSWIRE
Oculis to Present DME, Optic Neuritis Trial Data at Meetings
01 Sep 2025 //
GLOBENEWSWIRE
Oculis Upsized Loan Facility to Access up To CHF 100 Million
01 Aug 2025 //
GLOBENEWSWIRE
Oculis peptidomimetic helps protect eyes from nerve inflammation
06 Jan 2025 //
FIERCE BIOTECH
Oculis Reports Positive Licaminlimab Dry Eye Phase 2b Trial Data
10 Jun 2024 //
GLOBENEWSWIRE
Oculis Announces First Patient First Visit in Ph 2b RELIEF Trial of Licaminlimab
07 Dec 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.